LncRNA LINC01123 promotes malignancy of ovarian cancer by targeting hsa-miR-516b-5p/VEGFA

被引:2
作者
Dong, Bing [1 ]
Li, Cuiping [1 ]
Xu, Xiaomeng [1 ]
Wang, Yan [1 ]
Li, Yuewen [1 ]
Li, Xingmei [1 ]
机构
[1] Qiqihar Med Univ, Affiliated Hosp 3, Dept Gynaecol, 27,Taishun St, Qiqihar 161000, Heilongjiang, Peoples R China
关键词
Long non-coding RNA; LINC01123; Hsa-miR-516b-5p; VEGFA; Ovarian cancer; LONG NONCODING RNA; CELL LUNG-CANCER; PROLIFERATION; PROGRESSION; INVASION; METASTASIS; BIOMARKERS; PATHWAY; CASC15; LOOP;
D O I
10.1007/s13258-023-01440-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BackgroundLong non-coding RNAs (lncRNAs) play a critical role in the development of ovarian cancer (OC).ObjectiveThe study aimed to determine the role of LncRNA LINC01123 in OC bio-progression, which is upregulated in OC tissues during OC progression.MethodsBioinformatics methods, GEPIA, and qRT-PCR were used to reveal the level and correlation of LINC01123, hsa-miR-516b-5p, and VEGFA, in OC cell lines. MTT, EdU, TUNEL, and Transwell assays were performed to assess the bioactivity of OC cell. Target sites of LINC01123 and hsa-miR-516b-5p were predicted using Starbase, and the potential linkage points of VEGFA and hsa-miR-516b-5p were predicted using TargetScan. These sites and linkage points were confirmed by double luciferase reporter assay.ResultsLINC01123 was upregulated in OC cell lines and LINC01123 silencing suppressed the proliferation and metastasis of OC cells, but promoted cell apoptosis. hsa-miR-516b-5p was linked to LINC01123 and. VEGFA was downstream of hsa-miR-516b-5p. Importantly, silencing of hsa-miR-516b-5p reversed the inhibitory impact of si-LINC01123. The result of hsa-miR-516b-5p inhibitor + si-LINC01123 co-transfection were rescued by si-VEGFA.ConclusionLINC01123 promotes OC development by dampening miR-516b-5p function, and may be a novel target for treating OC.
引用
收藏
页码:231 / 239
页数:9
相关论文
共 50 条
  • [21] RETRACTED: STAT1-induced upregulation of lncRNA LINC01123 predicts poor prognosis and promotes the progression of endometrial cancer through miR-516b/KIF4A (Retracted article. See MAR, 2023)
    Yang, Yuguang
    Wu, Jin
    Zhou, Hongfeng
    Liu, Wenming
    Wang, Jincai
    Zhang, Qingyuan
    CELL CYCLE, 2020, 19 (12) : 1502 - 1516
  • [22] LncRNA LINC00460 promotes tumor growth of human lung adenocarcinoma by targeting miR-302c-5p/FOXA1 axis
    Ye, Jun-Jie
    Cheng, Yan-Lei
    Deng, Jun-Jian
    Tao, Wei-Ping
    Wu, Long
    GENE, 2019, 685 : 76 - 84
  • [23] LncRNA GAPLINC Promotes Renal Cell Cancer Tumorigenesis by Targeting the miR-135b-5p/CSF1 Axis
    Wang, Siyuan
    Yang, Xiaorong
    Xie, Wenjie
    Fu, Shengqiang
    Chen, Qiang
    Li, Zhilong
    Zhang, Zhicheng
    Sun, Ting
    Gong, Binbin
    Ma, Ming
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [24] RETRACTED: LncRNA SNHG16 promotes tumor growth of pancreatic cancer by targeting miR-218-5p (Retracted Article)
    Liu, Songyang
    Zhang, Wei
    Liu, Kai
    Liu, Yahui
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 114
  • [25] Interference of long non-coding RNA HAGLROS inhibits the proliferation and promotes the apoptosis of ovarian cancer cells by targeting miR-26b-5p
    Zhu, Lin
    Mei, Mei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (02)
  • [26] LncRNA LUCAT1 promotes proliferation of ovarian cancer cells by regulating miR-199a-5p expression
    Liu, H-Z
    Liu, G-Y
    Pang, W-W
    Zhang, H.
    Zeng, Z-J
    Wang, H-J
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (04) : 1682 - 1687
  • [27] LncRNA LEFI-ASI Promotes Ovarian Cancer Development Through Interacting with miR-1285-3p
    Zhang, Yanan
    Ruan, Fang
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 687 - 694
  • [28] LncRNA EWSAT1 promotes ovarian cancer progression through targeting miR-330-5p expression
    Fu, Xin
    Zhang, Li
    Dan, Li
    Wang, Ke
    Xu, Yue
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2017, 9 (09): : 4094 - 4103
  • [29] LncRNA LINC00665 Promotes Prostate Cancer Progression via miR-1224-5p/SNDI Axis
    Chen, Wei
    Yu, Zhixian
    Huang, Weiping
    Yang, Yu
    Wang, Feng
    Huang, Hang
    ONCOTARGETS AND THERAPY, 2020, 13 : 2527 - 2535
  • [30] LINC00707 promotes multidrug resistance of ovarian cancer cells by targeting the miR-382-5p/LRRK2 axis
    Zhao, Min-Wen
    Lin, Chang-Jie
    Qiu, Jian-Ping
    ACTA BIOCHIMICA POLONICA, 2023, 70 (04) : 799 - 806